Conventional versus minimally invasive extra-corporeal circulation in patients undergoing cardiac surgery: A randomized controlled trial (COMICS).
Gianni Davide AngeliniBarnaby C ReevesLucy A CullifordRachel MaishmanChris A RogersKyriakos AnastasiadisPolychronis AntonitsisHelena ArgiriadouThierry CarrelDorothée KellerAndreas LieboldFatma AshkanianiAschraf El-EssawiIngo BreitenbachClinton LloydMark BennettAlex CaleSerdar GünaydinEren GunertemFarouk OueidaIbrahim M YassinCyril SerrickJohn M MurkinVivek RaoMarco MoscarelliIgnazzo CondelloPrakash P PunjabiCha RajakarunaApostolos DeliopoulosDaniel BoneWilliam LansdownNarain MoorjaniSarah DennisPublished in: Perfusion (2024)
MiECC reduces the relative risk of primary outcome events by about 25%. The risk of other SAEs was similarly reduced. Because the trial terminated early without achieving the target sample size, these potential benefits of MiECC are uncertain.